18:29 EDT 17th March 2018 | BioPortfolio

Cytos Biotechnology, ESBATech, Glycart Biotechnology, Prionics, and The Genetics Company together with the proprietary of the area, Gewerbe- und Handelszentrum Schlieren AG, and the Office for Economy and Labor of the Canton of Zurich jointly opened a major new center for the Swiss biotechnology industry on October 29, 2002.The opening of the BIOTECH CENTER ZURICH has led to the creation of more than 350 highly skilled new jobs in the Zurich area.

On the occasion of the inauguration, leading representatives from science, business and politics, including Swiss Minister Pascal Couchepin, shared their views on the future of the biotechnology industry and medicine at a symposium held at the new center.


Wagistrasse 25


Phone: 41 (0)76 336 9944
Fax: 41 (0)44 200 22 11

News Articles [2351 Associated News Articles listed on BioPortfolio]

How songbirds learn a new song

(ETH Zurich) As scientists from ETH Zurich and the University of Zurich have now shown, songbirds are minimalists when it comes to learning a new song. The birds' learning strategy resembles the metho...

Ono Bulks Up MAb R&D With Second Swiss Biotech Deal

Human-derived monoclonal antibodies targeted against neurodegenerative diseases is the subject of a deal between Japan's Ono Pharmaceutical and Zurich-based biotech...   


ETH Zurich - l'Istituto federale svizzero di tecnologia con sede a Zurigo, è presente con alcuni dei suoi principali ricercatori nel campo della robotica, dell'apprendimento Read more...

Workbench for virus design

(ETH Zurich) ETH's Zurich researchers have developed a technology platform that allows them to systematically modify and customise bacteriophages. This technology is a step towards making phage therap...

Proven Telecom Entrepreneurs Join Forces To Launch Telecom And IT Network Equipment And ...

The company is now serving clients with over $20Min searchable inventory on the Zurich Technology Solutions Website Zurich Cofounder and CEO Craig Read more...

Exit through the lymphatic system

(ETH Zurich) ETH Zurich scientists have disproved a decades-old orthodoxy: cerebrospinal fluid does not leave the cranial cavity via blood vessels, but instead through the lymphatic system. This findi...

Senior Citi Banker Joins additiv to Head Up Asia Pacific Business

ZURICH, Jan. 27, 2018/PRNewswire/ -- Zurich-based additiv, a leading provider of digitalization solutions to the financial services industry, has hired Adrian Weiss, regional Read more...

#jobs #lifescience Contact Center Representative

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Contact Center Representative .CA-San Diego, Are you looking for an opportuni...

PubMed Articles [567 Associated PubMed Articles listed on BioPortfolio]

Biotech Crop Planting Resumes High Adoption in 2016.

The global area of biotech crops in 2016 increased from 179.7 million hectares to 185.1 million hectares, a 3% increase equivalent to 5.4 million hectares. Some 26 countries planted biotech crops, 19 ...

Just how good an investment is the biopharmaceutical sector?

Uncertainty surrounding the risk and reward of investments in biopharmaceutical companies poses a challenge to those interested in funding such enterprises. Using data on publicly traded stocks, we tr...

On the biotech block.

Comparison of the Center and Flex-Center Methods of Corneal Endothelial Cell Analysis in the Presence of Guttae.

To compare endothelial cell analysis by the center and flex-center methods in corneas with guttae of differing severity and to determine the minimum countable cell number for using only the flex-cente...

Third-quarter biotech job picture.

Clinical Trials [1568 Associated Clinical Trials listed on BioPortfolio]

Retrospective Data Analysis of Data From the Zurich PH Registry

The collected data from the Zurich Registry for pulmonary Hypertension (PH) are evaluated in a retrospective analysis. This study examines the number of patients and their exact diagnoses ...

Physiotherapy for Chronic Metatarsalgia

The pilot study was conducted in the form of an open prospective single-arm observational study with 28 patients who received physiotherapy at the Spiraldynamik® Med Center in Zurich.

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study

Aim of the study: To describe the epidemiology, longitudinally follow, test the effect of early antiretroviral treatment and investigate early events of virus-host interactions in patients...

Companies [2278 Associated Companies listed on BioPortfolio]


Cytos Biotechnology, ESBATech, Glycart Biotechnology, Prionics, and The Genetics Company together with the proprietary of the area, Gewerbe- und Handelszentrum Schlieren AG, and the Office for Economy...


Zurich in North America is a part of Zurich Financial Services Group (Zurich), an insurance-based financial services provider with a global network of subsidiaries and offices in ...


Founded in Zurich in 2006, Xeltis is a privately held biomedical technology company focused on developing autologous growing, living and self-healing cardiovascular implants using...

Zurich MedNet

Zurich MedNet offers through it's web-portal a strong service platform for the virtual community cluster of medical and biotechnologies.

Dualsystems Biotech AG

Dualsystems Biotech AG was privately founded in the summer of 2000. Its business plan is certified with the KTI-label by the “Kommission für Technologie und Innovation” (KTI), which also collabor...

More Information about "BIOTECH CENTER ZURICH" on BioPortfolio

We have published hundreds of BIOTECH CENTER ZURICH news stories on BioPortfolio along with dozens of BIOTECH CENTER ZURICH Clinical Trials and PubMed Articles about BIOTECH CENTER ZURICH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BIOTECH CENTER ZURICH Companies in our database. You can also find out about relevant BIOTECH CENTER ZURICH Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Corporate Database Quicklinks

Searches Linking to this Company Record